GAMMA Investing LLC Grows Position in Humana Inc. (NYSE:HUM)

GAMMA Investing LLC raised its stake in shares of Humana Inc. (NYSE:HUM) by 41.0% during the 4th quarter, Holdings Channel.com reports. The fund owned 1,906 shares of the insurance provider’s stock after acquiring an additional 554 shares during the period. GAMMA Investing LLC’s holdings in Humana were worth $484,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in HUM. Marshall Wace LLP boosted its holdings in Humana by 118.9% during the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after purchasing an additional 774,085 shares during the last quarter. International Assets Investment Management LLC boosted its stake in shares of Humana by 261,025.1% in the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock worth $2,340,660,000 after buying an additional 738,701 shares during the last quarter. FMR LLC grew its holdings in shares of Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after acquiring an additional 643,291 shares in the last quarter. Baupost Group LLC MA purchased a new stake in shares of Humana during the second quarter valued at approximately $156,933,000. Finally, Thrivent Financial for Lutherans lifted its holdings in Humana by 639.8% during the second quarter. Thrivent Financial for Lutherans now owns 385,782 shares of the insurance provider’s stock worth $144,147,000 after acquiring an additional 333,636 shares during the period. Institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on HUM shares. Sanford C. Bernstein upgraded Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective for the company in a research note on Tuesday, October 8th. Morgan Stanley raised their price objective on shares of Humana from $288.00 to $301.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Truist Financial reduced their target price on shares of Humana from $400.00 to $260.00 and set a “hold” rating for the company in a research report on Friday, October 11th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $395.00 price target on shares of Humana in a report on Tuesday, October 1st. Finally, Stephens reissued an “equal weight” rating and set a $250.00 price objective on shares of Humana in a report on Wednesday, October 9th. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $300.50.

Humana Price Performance

Shares of NYSE HUM opened at $262.47 on Monday. The stock’s 50-day simple moving average is $272.60 and its two-hundred day simple moving average is $313.45. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $471.37. The firm has a market capitalization of $31.60 billion, a P/E ratio of 23.25, a P/E/G ratio of 2.12 and a beta of 0.55. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. As a group, equities analysts anticipate that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio is currently 31.36%.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.32% of the stock is owned by company insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.